Remi Barbier

Remi Barbier

Former President and Chief Executive OfficeratFilana Therapeutics· In proxies 2021–2024

Pay in FY2024-41% from the year before · Filana Therapeutics stock -89.5% the same year

Remi Barbier was paid $3.7M in FY2024 (Dec), down 41%. Filana Therapeutics stock fell 89.5% that year.

Pay$100 in the stock at the end of FY20 → $35
Pay is from the Summary Compensation Table of each Filana Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Filana TherapeuticsPublic company · 5 yr
    • Former President and Chief Executive Officer2021 – Present · 5 yrStock in role -91%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?